Transforming Women's Healthcare at Every Stage of Life
Specialdocs Launches Concierge OB/GYN Practice with Prominent NoVA Physicians
11. September 2024 20:00 ET | Specialdocs Consultants
Chicago, IL, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Working with Specialdocs Consultants, a pioneer in concierge medicine practice conversions and management, highly respected OB/GYN physicians Manisha...
Gynesonics Logo.jpg
Gynesonics® Reaches Milestone with 10,000th Patient Treatment with Sonata System
20. August 2024 10:30 ET | Gynesonics
REDWOOD CITY, Calif., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Gynesonics®, Inc. a privately-held women’s healthcare medical device company focused on the development of minimally invasive solutions for...
Breakdown of reasons given by women who canceled plans due to a gynecological condition.
National Poll Shows Women Are Missing Out on Vacations, Work, and Social Events Due to Gynecological Conditions
02. Mai 2024 10:00 ET | LevLane
PHILADELPHIA, May 02, 2024 (GLOBE NEWSWIRE) -- LevLane Advertising, one of Philadelphia's oldest independent full-service advertising agencies, today released the findings of a women's health survey...
Ted-Stephens-300x300
Gynesonics Announces Key Executive Appointments to Further Accelerate and Expand Adoption of the Sonata Treatment
19. März 2024 10:00 ET | Gynesonics
Gynesonics announces key executive appointments to further accelerate and expand adoption of the Sonata Treatment.
Gynesonics Logo.jpg
Gynesonics Announces New Category 1 CPT Code for its Sonata Transcervical RF Ablation Procedure Used to Treat Uterine Fibroids
02. Januar 2024 11:13 ET | Gynesonics
Gynesonics Announces New Category 1 CPT Code for its Sonata Transcervical RF Ablation Procedure Used to Treat Uterine Fibroids
Gynesonics Logo.jpg
Gynesonics Announces $67M Financing to Expand Commercialization of Sonata® Procedure
02. November 2023 09:41 ET | Gynesonics
Gynesonics Announces $67M Financing to Expand Commercialization of Sonata® Procedure
Adynproduct2021-9 (1) (2)
adyn Launches First Test Designed to Prevent Birth Control Side Effects
23. Mai 2022 13:00 ET | Adyn, Inc.
SEATTLE, May 23, 2022 (GLOBE NEWSWIRE) -- adyn, the first to create a test designed to prevent birth control side effects, announced today the official launch of its flagship product, The Birth...
clear background.png
Fogarty Innovation Graduate Raydiant Oximetry Raises $5 Million in Oversubscribed Series A2 Financing Round to Support Clinical Study
02. November 2021 12:00 ET | Fogarty Innovation
MOUNTAIN VIEW, Calif. and SAN RAMON, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Fogarty Innovation, a nonprofit educational incubator for medical technology companies, announced today that its...
Evofem logo
Evofem, Inc. Appoints Louis Villalba as Chief Business Officer
20. Februar 2015 09:10 ET | Evofem
SAN DIEGO, Feb. 20, 2015 (GLOBE NEWSWIRE) -- Evofem, Inc. announces that Louis Villalba has been named Chief Business Officer (CBO), effective immediately. Mr. Villalba comes to Evofem with years of...